Meanwhile, the results also revealed that downregulation or upregulation of DDX24 elevated or suppressed sorafenib-mediated inhibition of migration ability in HCC cells via the EMT pathway, respectively. The gene discussed is DDX24; the disease is hepatocellular carcinoma.